Moderna shares nearly triple on skin cancer vaccine success
Drugmaker’s melanoma shot developed with Merck delivers positive outcome in late-stage trial
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.ft.com — the content belongs to Financial Times.
